Tempus AI (NASDAQ:TEM) Price Target Raised to $100.00

Tempus AI (NASDAQ:TEM) had its target price hoisted by Needham & Company LLC from $70.00 to $100.00 in a research note issued to investors on Wednesday morning,Benzinga reports. Needham & Company LLC currently has a buy rating on the stock.

Other equities analysts also recently issued research reports about the company. Cowen downgraded Tempus AI from a “buy” rating to a “hold” rating in a research report on Tuesday, October 21st. Morgan Stanley boosted their target price on shares of Tempus AI from $65.00 to $68.00 and gave the company an “overweight” rating in a research note on Tuesday, August 12th. TD Cowen downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 price target on the stock. in a research note on Tuesday, October 21st. BTIG Research lifted their price objective on shares of Tempus AI from $85.00 to $96.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Tempus AI in a research note on Wednesday, October 8th. Seven research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $79.85.

Tempus AI Stock Performance

Shares of NASDAQ:TEM opened at $71.56 on Wednesday. The company has a current ratio of 3.28, a quick ratio of 1.43 and a debt-to-equity ratio of 2.45. Tempus AI has a 12 month low of $31.36 and a 12 month high of $104.32. The company has a market capitalization of $12.43 billion, a price-to-earnings ratio of -60.13 and a beta of 4.86. The firm’s 50-day moving average is $85.91 and its 200 day moving average is $70.82.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings data on Tuesday, November 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.16) by $0.05. The business had revenue of $334.21 million during the quarter, compared to the consensus estimate of $328.89 million. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. The firm’s quarterly revenue was up 84.7% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.46) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. Research analysts predict that Tempus AI will post -6.15 EPS for the current year.

Insider Transactions at Tempus AI

In related news, CFO James William Rogers sold 7,528 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $561,965.20. Following the completion of the sale, the chief financial officer directly owned 138,473 shares of the company’s stock, valued at $10,337,009.45. This represents a 5.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director David R. Epstein sold 370 shares of the firm’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $90.00, for a total transaction of $33,300.00. Following the transaction, the director directly owned 26,671 shares in the company, valued at $2,400,390. This trade represents a 1.37% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 1,105,282 shares of company stock valued at $87,726,381 over the last three months. 26.27% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Tempus AI

Several institutional investors have recently bought and sold shares of the business. GSA Capital Partners LLP purchased a new stake in Tempus AI during the third quarter worth $604,000. Vanguard Group Inc. increased its holdings in shares of Tempus AI by 22.1% in the 3rd quarter. Vanguard Group Inc. now owns 9,441,607 shares of the company’s stock valued at $762,032,000 after acquiring an additional 1,706,837 shares during the period. State of New Jersey Common Pension Fund D raised its position in shares of Tempus AI by 4.2% in the 3rd quarter. State of New Jersey Common Pension Fund D now owns 33,111 shares of the company’s stock worth $2,672,000 after acquiring an additional 1,323 shares in the last quarter. PNC Financial Services Group Inc. raised its position in shares of Tempus AI by 16.2% in the 3rd quarter. PNC Financial Services Group Inc. now owns 5,815 shares of the company’s stock worth $469,000 after acquiring an additional 812 shares in the last quarter. Finally, Ameritas Advisory Services LLC purchased a new stake in shares of Tempus AI during the 3rd quarter worth $843,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.